Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...

Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.561 billion during the fourth quarter of 2024 ...

To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP ...

Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant ...

Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...

Credit: Shutterstock / Good dreams – Studio US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients with paroxysmal atrial ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $110.00. The company’s shares closed ...

Boston Scientific CEO Mike Mahoney told investors the company’s PFA launch is rapidly increasing its share of the electrophysiology market, while Intuitive Surgical CEO Gary Guthart shared surgeon ...

Bringing Pittcon to Boston represents a perfect alignment of mission and location,” said Heather Juzwa, President of Pittcon 2025. “The city’s concentration of scientific talent, from ...

The Farapulse (left) and Watchman FLX Pro (right) systems. [Images courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + today reported data from separate studies backing its Farapulse ...